The UAE has become the second country to approve once-daily, oral pill - Lipfendra - to treat adults with elevated low-density lipoprotein (LDL-C) cholesterol, a leading risk factor for cardiovascular disease.
Making the announcement, the Emirates Drug Establishment (EDE) explained that Lipfendra can also treat "certain inherited conditions" as long as it is cleared by a healthcare professional.
It is said to expand treatment options for adults and improve their quality of life.
Patients are advised to maintain a balanced diet and regular physical activity alongside the treatment.
The move is part of efforts by the UAE to authorise innovative medicines and expand treatment options for adults.
UAE join 7 nations in condemning Israeli rejection of Gaza peace plan
UAE gives motorists chance to reduce black points on 'Accident-Free Day'
683 tonnes of aid enter Gaza Strip under UAE's Operation Chivalrous Knight 3
Museum of Illusion announces permanent closure in Al Seef
Gargash: ADNOC tankers' targeting will not deter UAE from moving forward
